{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:30Z","timestamp":1761630690723},"reference-count":0,"publisher":"Portico","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2014.50.4.2133570","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T09:20:41Z","timestamp":1403601641000},"page":"291","source":"Crossref","is-referenced-by-count":22,"title":["Ibrutinib for the treatment of chronic lymphocytic leukemia and\nmantle cell lymphoma"],"prefix":"10.3730","volume":"50","author":[{"family":"McDermott, J.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Jimeno, A.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2014]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:27:55Z","timestamp":1685453275000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dd827j"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2014.50.4.2133570","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}